“AI and machine learning are like a new microscope that will help scientists to see things that they couldn’t see otherwise. NVIDIA’s investment in computing, combined with the power of deep learning, will enable solutions to some of the life sciences industry’s greatest challenges and help us continue to deliver transformational medicines and vaccines to patients. Together with GSK’s new AI lab in London, I am delighted that these advanced technologies will now be available to help the UK’s outstanding scientists.”

— Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK

“Recent advances in AI have seen increasingly powerful models being used for complex tasks such as image recognition and natural language understanding. These models have achieved previously unimaginable performance by using an unprecedented scale of computational power, amassing millions of GPU hours per model. Through this partnership, for the first time, such a scale of computational power will be available to healthcare research—it will be truly transformational for patient health and treatment pathways.”

— Sebastien Ourselin, Head of the School of Biomedical Engineering and Imaging Sciences, King's College London

“Compact AI has enabled real-time sequencing in the palm of your hand, and AI supercomputers are enabling new scientific discoveries in large-scale genomic datasets. These complementary innovations in data analysis support a wealth of impactful science in the UK and, critically, support our goal of bringing genomic analysis to anyone, anywhere.”

— Gordon Sanghera, CEO, Oxford Nanopore Technologies